Patients Discontinuing Anti-Obesity Jabs Gain Back Weight Far More Rapidly Compared to Those on Conventional Diets

A recent study reveals that individuals who discontinue popular weight-loss injections like Wegovy and Mounjaro tend to recover shed pounds far faster than those who end conventional diet and exercise programs.

Findings released in a prominent medical journal shows that while obese individuals frequently drop substantial amounts of their total mass while undergoing treatment, the mass is regained at an average rate of 0.8 kg per month after stopping.

"Users using such drugs need to be cognizant of the risk of quick weight regain when the therapy concludes," stated researcher Dr. Susan Jebb.

This pace of recovery suggests a reversion to pre-treatment mass in about 18 months.

Comparing Therapies

The study, which reviewed dozens of studies involving over 9,000 of participants, contrasted the effects of these new drugs with other pills.

Scientists emphasize that individuals who lose weight through dieting typically have a less rapid creep back—around 100 grams monthly—post-intervention.

Understanding the Fast Regain

Experts suggest the mechanism of the drugs accounts for the heightened rebound.

The injections imitate a natural hormone called glucagon-like peptide-1, which helps regulate feelings of fullness.

"Long-term administration of the hormone concentrations several times higher than normal may cause the body to produce less of its own natural hormone, and may also diminish sensitivity to its actions," said Dr. Adam Collins, a dietetics specialist.

"Stopping of this hormone supplement means appetite is unsuppressed, making binge eating a significant risk."

An Ongoing Condition?

The NHS suggest the jabs for individuals with weight-linked medical conditions, alongside recommended diet and exercise modifications.

Professionals contend that, considering the likelihood of relapse, the therapy might need to be life-long.

This perspective is supported by drug manufacturers, who note that the results "underscore the persistent nature of excess weight," akin to managing diseases like diabetes.

Patient Testimonies

People who have discontinued the medication report a intense resurgence of cravings.

"It felt as if a switch that goes on and you become ravenous," said one woman.

This difficulty is exacerbated if patients have not developed sustainable lifestyle or habit changes during treatment.

Growing Use

Figures show that a significant number of people in the UK have used these injections in the last 12 months, with demand being substantial.

• Adoption is greater among females compared to men.
• The middle-aged age group shows the greatest level of interest.
• A large proportion access the drugs through private prescriptions rather than public health services.

In conclusion, experts caution that while GLP-1 drugs are effective agents for shedding pounds, they are not a standalone solution and long-term success likely depends on combined behavioural management.